PACS Group CEO Jason Hulse Murray sells 118,729 shares

PACS Group's CEO and chairman made the reported sales under a Rule 10b5-1 plan adopted May 18, 2026.

Rhea-AI Filing Summary

PACS Group, Inc.'s Co-Founder, CEO & Chairman, Jason Hulse Murray, sold 118,729 shares of common stock in six direct transactions from October 14 through October 16, 2026. The sales were made under a Rule 10b5-1 trading plan adopted May 18, 2026. The reported price was $45.0000 for 232 shares on October 14; weighted-average prices were $45.6117 for 4,633 shares, $46.7837 for 24,800 shares, $47.4916 for 77,540 shares, and $48.1052 for 3,062 shares on October 15; and $47.6100 for 8,462 shares on October 16.

Insider Trade Summary 10b5-1

Net Seller: 118,729 shares

Net Sell 6 txns

Insider Murray Jason Hulse

Role Co-Founder, CEO & Chairman

Sold 118,729 shs ($5.61M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F6	8,462	$47.61	$403K
Sale	Common Stock F1, F2	4,633	$45.6117	$211K
Sale	Common Stock F1, F3	24,800	$46.7837	$1.16M
Sale	Common Stock F1, F4	77,540	$47.4916	$3.68M
Sale	Common Stock F1, F5	3,062	$48.1052	$147K
Sale	Common Stock F1	232	$45.00	$10K

Holdings After Transaction: Common Stock — 54,316,520 shares (Direct)

Footnotes (6)

1. F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
2. F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.075 to $46.065 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $46.08 to $47.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.075 to $48.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. F5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $48.08 to $48.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. F6. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.14 to $47.89 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 118,729 shares Shares sold and weighted-average price: 4,633 shares at $45.6117 per share Shares sold and weighted-average price: 24,800 shares at $46.7837 per share +4 more

7 metrics

Shares sold 118,729 shares Six direct transactions from October 14 through October 16, 2026

Shares sold and weighted-average price 4,633 shares at $45.6117 per share October 15, 2026

Shares sold and weighted-average price 24,800 shares at $46.7837 per share October 15, 2026

Shares sold and weighted-average price 77,540 shares at $47.4916 per share October 15, 2026

Shares sold and weighted-average price 3,062 shares at $48.1052 per share October 15, 2026

Shares sold and weighted-average price 8,462 shares at $47.6100 per share October 16, 2026

Shares sold and reported price 232 shares at $45.0000 per share October 14, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average price

2 terms

Rule 10b5-1 trading plan regulatory

"effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"the price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PACS shares did Jason Hulse Murray sell, and at what prices?

Jason Hulse Murray sold 118,729 shares from October 14 through October 16, 2026. The reported price was $45.0000 for 232 shares on October 14; weighted-average prices on October 15 were $45.6117 for 4,633 shares, $46.7837 for 24,800 shares, $47.4916 for 77,540 shares, and $48.1052 for 3,062 shares; the October 16 weighted-average price was $47.6100 for 8,462 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/16/2026 - 06:00 PM EDT Accepted by SEC EDGAR 10/16/2026 - 06:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Murray Jason Hulse

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Founder, CEO & Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/14/2026		S(1)		232	D	$45	54,435,017	D
Common Stock	10/15/2026		S(1)		4,633	D	$45.6117(2)	54,430,384	D
Common Stock	10/15/2026		S(1)		24,800	D	$46.7837(3)	54,405,584	D
Common Stock	10/15/2026		S(1)		77,540	D	$47.4916(4)	54,328,044	D
Common Stock	10/15/2026		S(1)		3,062	D	$48.1052(5)	54,324,982	D
Common Stock	10/16/2026		S(1)		8,462	D	$47.61(6)	54,316,520	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.

2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.075 to $46.065 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $46.08 to $47.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.075 to $48.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $48.08 to $48.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.14 to $47.89 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Trevor Petersen, Attorney-in-Fact	10/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)